Sponsor Check › Person
Named as an officer, director or promoter on SEC Form D filings · CA · Mar 2, 2011 → Jun 8, 2026
Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:16 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET
Patrick Enright is listed as an executive officer and director on 33 SEC Form D filings by 16 issuers between Mar 2011 and Jun 2026. Largest by amount reported sold: Longitude Venture Partners III, L.P. (Menlo Park, CA — pooled investment fund — 2016; $525M reported sold to 70 investors), Longitude Venture Partners II, L.P. (Menlo Park, CA — pooled investment fund — 2011–2012; $385M reported sold to 46 investors), Longitude Venture Partners V, L.P. (Menlo Park, CA — pooled investment fund — 2022–2023; $206.7M reported sold to 18 investors), BioAge Labs, Inc. (Richmond, CA — biotechnology — 2024; $194.4M reported sold to 32 investors), Aimmune Therapeutics, Inc. (Brisbane, CA — other health care — 2015; $156.7M reported sold to 10 investors) and 11 more (all listed below).
What this means That is a lot of deals — 16 separate companies raised money with this person listed as executive officer and director, over about 15 years. Across those companies the filings report $1.94B sold in total.
Listed alongside Juliet Tammenoms Bakker (14 shared filings), Kurt von Emster (6 shared filings), Anthony P. Ford (5 shared filings), Benjamin Potter (5 shared filings), Kathleen Sereda Glaub (5 shared filings) and 66 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Patrick. Each name links to their own page.
8 of the issuers belong to the sponsor group Longitude Venture (8 issuers, $1.27B reported sold, 2011–2025).
What this means A sponsor group is one team that sets up a new company for each deal. Longitude Venture has 8 companies on file and $1.27B reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 1 bankruptcy case matching the name listed in Key records below.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 33 public filings for Patrick Enright and found 17 differences, 3 worth asking the sponsor about: Patrick Enright appears on 7 deals that stopped filing before reaching their target; 4 paid sellers are listed without a CRD number; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.
Community search for Patrick Enright has not run yet — it is joining a line of 24,604 names; searches run around the clock at the hosts' allowed rate. Searched so far: 638 names.
Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).
Five things investors ask first. Items still in human review are counted, not shown.
None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:16 AM ET.
State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: VA (crawled Oct 23, 2026)
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Patrick Enright..
State securities regulators: Securities regulators searched (3,318 actions): AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE DOJ Investor Protection Unit (257 actions, 1987–2026), TX State Securities Board (586 actions, 2006–2026), WA DFI (2,039 actions, 2001–2026) — last crawled Oct 23, 2026, 9:57 PM ET. No machine-readable public listing today for CO, FL, IA, IN, MN, NE, NJ, NY, OH, UT, VA (see docs/state-regulators.md).
1 case: 1 closed (disposition not in docket feed)
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:16 AM ET.
Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.
State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
Comparisons cover issuers and sponsor groups — see the issuer pages under Deals
17 differences found between the filings for Patrick Enright — 3 worth asking about (compared 33 filings on Oct 24, 2026)
United States Bankruptcy Court, C.D. California docket "Stussy Inc v. Hemrajani" filed Jan 9, 2002, closed May 31, 2005. Rehka Hemrajani (listed on the same filings) is listed as Defendant ("Hemrajani"). Our match estimate: 70%.
What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.
United States Bankruptcy Court, N.D. California docket "First USA Bank, N.A. v. Seidenberg" filed Nov 18, 1999, closed Feb 14, 2000. Beth Seidenberg (listed on the same filings) is listed as Defendant ("Seidenberg"). Our match estimate: 70%.
What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.
CuraSen Therapeutics, Inc. (last filing Sep 18, 2024; $27,249,994 sold of $54,499,989); Longitude Venture Partners V, L.P. (last filing Jul 20, 2023; $206,679,375 sold of $600,000,000); Longitude Prime Fund II, L.P. (last filing Jul 20, 2023; $49,861,875 sold of $200,000,000); Longitude Prime Fund, L.P. (last filing Jun 17, 2021; $0 sold of $130,000,000); Orbus Therapeutics, Inc. (last filing Aug 11, 2020; $18,500,014 sold of $39,500,024); Longitude Venture Partners IV, L.P. (last filing Sep 20, 2019; $0 sold of $550,000,000); and 1 more. Each has no filing in more than two years and reported under half its target sold.
What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.
Paid seller listed without a CRD number: First Forte Consultancy FZE — Longitude Venture Partners V, L.P. · Paid seller listed without a CRD number: First Forte Consultancy FZE — Longitude Prime Fund II, L.P. · Paid seller listed without a CRD number: Gencap Global Advisors DMCC — Longitude Prime Fund II, L.P. · Paid seller listed without a CRD number: Gencap Global Advisors DMCC — Longitude Venture Partners V, L.P.
What this means Without a CRD number we cannot look a seller up on BrokerCheck. Ask who they are and whether they are registered.
Form D filed 119 days after the first sale — Vera Therapeutics, Inc. · Form D filed 129 days after the first sale — CuraSen Therapeutics, Inc. · Form D filed 63 days after the first sale — Aimmune Therapeutics, Inc. · Form D filed 18 days after the first sale — Infinant Health, Inc. · Form D filed 23 days after the first sale — CuraSen Therapeutics, Inc. · and 1 more
What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.
No amendment in the last 12 months on an offering that may still be open — CuraSen Therapeutics, Inc. (latest filing Sep 18, 2024) · No amendment in the last 12 months on an offering that may still be open — CuraSen Therapeutics, Inc. (latest filing Oct 12, 2023) · No amendment in the last 12 months on an offering that may still be open — Longitude Prime Fund II, L.P. (latest filing Jul 20, 2023) · No amendment in the last 12 months on an offering that may still be open — Longitude Venture Partners V, L.P. (latest filing Jul 20, 2023) · No amendment in the last 12 months on an offering that may still be open — Orbus Therapeutics, Inc. (latest filing Aug 11, 2020) · and 8 more
What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.
The Nov 10, 2022 filing says $14,999,997 offered; the Oct 12, 2023 Form D/A says $20,814,709.
What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.
The Aug 15, 2017 filing says $24,500,012 offered; the Mar 20, 2019 Form D/A says $39,500,024.
What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.
The Sep 5, 2012 filing says $375,000,000 offered; the Oct 23, 2012 Form D/A says $385,000,000.
What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.
This page covers filings where the address state is CA. A separate record, "Patrick Enright" with address state CT, is listed on 3 filings — most recently by Veradermics, Inc (May 15, 2026). Both records have filings in the same period (Dec 10, 2024 to May 15, 2026).
What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.
This page covers filings where the address state is CA. A separate record, "Patrick Enright" with address state PA, is listed on 6 filings — most recently by INFACARE PHARMACEUTICAL CORP (Jun 7, 2017). Both records have filings in the same period (Mar 20, 2013 to Jun 7, 2017).
What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.
This page covers filings where the address state is CA. A separate record, "Patrick G. Enright" with address state IL, is listed on 1 filing — most recently by Aptinyx Inc. (May 19, 2016). Both records have filings in the same period (May 19, 2016).
What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.
This page covers filings where the address state is CA. A separate record, "Patrick G. Enright" with address state MI, is listed on 1 filing — most recently by Esperion Therapeutics, Inc. (Apr 26, 2013). Both records have filings in the same period (Apr 26, 2013).
What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.
This page covers filings where the address state is CA. A separate record, "Patrick Enright" with address state KY, is listed on 1 filing — most recently by XANODYNE PHARMACEUTICALS INC (Oct 30, 2009). The two records do not overlap in time: this page runs Mar 2, 2011 to Jun 8, 2026; the other has one filing dated Oct 30, 2009.
What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.
The people listed on the Jan 25, 2019 filing give San Mateo, CA; on the Nov 5, 2021 filing they give San Carlos, CA. The address now on file (733 Industrial Road, San Carlos, CA) is a registered-agent or shared-office address used by 7 issuers.
What this means A registered agent's address is a mailbox, not where the team works. Ask where the business actually operates.
The people listed on the Aug 21, 2015 filing give Aptos, CA; on the Aug 15, 2017 filing they give Palo Alto, CA. The address now on file (2479 East Bayshore Road, Palo Alto, CA) is a registered-agent or shared-office address used by 8 issuers.
What this means A registered agent's address is a mailbox, not where the team works. Ask where the business actually operates.
The people listed on the Jul 24, 2015 filing give South San Francisco, CA; on the Mar 21, 2017 filing they give Foster City, CA.
What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.
What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.
2 of 25 offerings report sales commissions totalling $5,200,000; 0 report finder's fees; 1 reports proceeds to related persons totalling $2,279,507. (includes amounts the issuer reported as estimates)
| Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it | Source |
|---|---|---|---|---|---|
| Jun 8, 2026 D Infinant Health, Inc. File 021-586604 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Nov 13, 2025 D Longitude 103.8 East, L.P. File 021-563900 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Sep 18, 2024 D CuraSen Therapeutics, Inc. File 021-524399 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Feb 13, 2024 D BioAge Labs, Inc. File 021-505095 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Oct 12, 2023 D/A CuraSen Therapeutics, Inc. File 021-464469 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jul 20, 2023 D/A Longitude Prime Fund II, L.P. File 021-453315 | $0 (est.) | $0 (est.) | $0 (est.) The Issuer will pay an affiliate of the General Partner a quarterly management fee generally equal to a percentage of the Issuer's capital commitments or invested capital as specified in the Issuer's partnership agreement. | Snowbridge Securities LLC BrokerCheck CRD 301996 ↗ J.P. Morgan Securities LLC BrokerCheck CRD 79 ↗ First Forte Consultancy FZE no CRD number reported | EDGAR ↗ |
| Jul 20, 2023 D/A Longitude Venture Partners V, L.P. File 021-453320 | $0 (est.) | $0 (est.) | $0 (est.) The Issuer will pay an affiliate of the General Partner a quarterly management fee generally equal to a percentage of the Issuer's capital commitments or invested capital as specified in the Issuer's partnership agreement. | Snowbridge Securities LLC BrokerCheck CRD 301996 ↗ J.P. Morgan Securities LLC BrokerCheck CRD 79 ↗ First Forte Consultancy FZE no CRD number reported | EDGAR ↗ |
| Nov 5, 2021 D CuraSen Therapeutics, Inc. File 021-420132 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jun 17, 2021 D Longitude Prime Fund, L.P. File 021-403392 | $0 | $0 | $0 (est.) An affiliate of the General Partner will receive an annual management fee payable by the Issuer in advance. The management fee will generally be equal to a percentage of commitments or invested capital as specified in the Issuer's partnership agreement. | None listed on this filing | EDGAR ↗ |
| Feb 25, 2021 D Vera Therapeutics, Inc. File 021-390559 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Aug 11, 2020 D Orbus Therapeutics, Inc. File 021-372998 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Apr 3, 2020 D SutroVax, Inc. File 021-364301 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Sep 20, 2019 D Longitude Venture Partners IV, L.P. File 021-349320 | $0 | $0 | $0 An affiliate of the General Partner will receive an annual management fee payable by the Issuer in advance. The management fee will generally be equal to a percentage of commitments or invested capital as specified in the Issuer's partnership agreement. | None listed on this filing | EDGAR ↗ |
| Mar 20, 2019 D/A Orbus Therapeutics, Inc. File 021-292854 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jan 25, 2019 D CuraSen Therapeutics, Inc. File 021-331349 | $0 | $0 | $0 (est.) | None listed on this filing | EDGAR ↗ |
| Jun 12, 2018 D SutroVax, Inc. File 021-314375 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Mar 21, 2017 D SutroVax, Inc. File 021-282968 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jun 23, 2016 D/A Longitude Venture Partners III, L.P. File 021-262846 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Aug 21, 2015 D Orbus Therapeutics, Inc. File 021-246228 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jul 24, 2015 D SutroVax, Inc. File 021-244425 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Mar 24, 2015 D Aimmune Therapeutics, Inc. File 021-236500 | $0 | $0 | $0 | N/A no CRD number reported | EDGAR ↗ |
| Oct 23, 2012 D/A Longitude Venture Partners II, L.P. File 021-165828 | $3,000,000 (est.) | $0 | $0 (est.) | Probitas Funds Group, LLC BrokerCheck CRD 115876 ↗ | EDGAR ↗ |
| Aug 31, 2012 D CARDIODX INC File 021-183494 | $0 | $0 | $0 (est.) Proceeds will be used for general corporate purposes including, but not limited to, executive salaries. | None listed on this filing | EDGAR ↗ |
| Aug 9, 2011 D Longitude Capital Associates II, L.P. File 021-164089 | $2,200,000 (est.) | $0 | $0 (est.) | Probitas Fund Group, LLC BrokerCheck CRD 115876 ↗ | EDGAR ↗ |
| Mar 2, 2011 D CARDIODX INC File 021-156088 | $0 | $0 | $2,279,507 (est.) This estimate excludes amounts paid and that may be paid to the law firm which two executive officers were/are affiliated. | None listed on this filing | EDGAR ↗ |
Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across every filing this person is listed on (latest filing per offering, per issuer).
Every issuer that named Patrick Enright on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.
Raised $39.2M from 29 investors (33% of the $118.2M target) as of the latest filing. Patrick is listed as director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $100M from 1 investor (100% of the $100M target) as of the latest filing. Patrick is listed as executive officer.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $27.2M from 11 investors (60% of the $45.7M target) as of the latest filing. Patrick is listed as director on 5 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $194.4M from 32 investors (100% of the $194.4M target) as of the latest filing. Patrick is listed as director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $49.9M from 10 investors (25% of the $200M target) as of the latest filing. Patrick is listed as executive officer on 2 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $206.7M from 18 investors (34% of the $600M target) as of the latest filing. Patrick is listed as executive officer on 2 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
No sales reported yet as of the latest filing. Patrick is listed as executive officer.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $70.7M from 23 investors (100% of the $70.7M target) as of the latest filing. Patrick is listed as director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $18.5M from 16 investors (69% of the $27M target) as of the latest filing. Patrick is listed as director on 4 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $110M from 23 investors (100% of the $110M target) as of the latest filing. Patrick is listed as director on 4 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
No sales reported yet as of the latest filing. Patrick is listed as executive officer.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $525M from 70 investors (100% of the $525M target) as of the latest filing. Patrick is listed as executive officer, director on 3 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $156.7M from 10 investors (100% of the $80M target) as of the latest filing. Patrick is listed as director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $385M from 46 investors (100% of the $385M target) as of the latest filing. Patrick is listed as executive officer, director on 3 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.
Raised $57.5M from 28 investors (99% of the $58M target) as of the latest filing. Patrick is listed as director on 2 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.
No sales reported yet as of the latest filing. Patrick is listed as executive officer, director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.
Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.
Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.
Listed on the same filings as Patrick Enright. Their page shows their other deals.
Listed on the same filings as Patrick Enright. Their page shows their other deals.
Listed on the same filings as Patrick Enright. Their page shows their other deals.
Listed on the same filings as Patrick Enright. Their page shows their other deals.
Listed on the same filings as Patrick Enright. Their page shows their other deals.
Juliet Tammenoms Bakker is on 9 issuers in total — a repeat sponsor. Their page lists every one.
Kurt von Emster is on 13 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Patrick Enright. Their page shows their other deals.
Kathleen Sereda Glaub is on 5 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Patrick Enright. Their page shows their other deals.
Listed on the same filings as Patrick Enright. Their page shows their other deals.
Listed on the same filings as Patrick Enright. Their page shows their other deals.
Listed on the same filings as Patrick Enright. Their page shows their other deals.
Ernest Mario is on 6 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Patrick Enright. Their page shows their other deals.
Listed on the same filings as Patrick Enright. Their page shows their other deals.
Listed on the same filings as Patrick Enright. Their page shows their other deals.
Listed on the same filings as Patrick Enright. Their page shows their other deals.
William Newell is on 5 issuers in total — a repeat sponsor. Their page lists every one.
Peter Hirth is on 8 issuers in total — a repeat sponsor. Their page lists every one.
Patrick Heron is on 34 issuers in total — a repeat sponsor. Their page lists every one.
Brook Byers is on 22 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Patrick Enright. Their page shows their other deals.
Fred Cohen is on 24 issuers in total — a repeat sponsor. Their page lists every one.
Louis Lange is on 9 issuers in total — a repeat sponsor. Their page lists every one.
Rob Hopfner is on 5 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Patrick Enright. Their page shows their other deals.
Ashish Khanna is on 5 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Patrick Enright. Their page shows their other deals.
Listed on the same filings as Patrick Enright. Their page shows their other deals.
Listed on the same filings as Patrick Enright. Their page shows their other deals.
Listed on the same filings as Patrick Enright. Their page shows their other deals.
Beth Seidenberg is on 29 issuers in total — a repeat sponsor. Their page lists every one.
Maha Katabi is on 8 issuers in total — a repeat sponsor. Their page lists every one.
William Ericson is on 12 issuers in total — a repeat sponsor. Their page lists every one.
One team, 8 deal companies. Patrick Enright is listed on 8 of them.
Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Patrick Enright.
A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.
None of the 16 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.
Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.
Property records are matched to companies only, never to individuals, so none are matched to Patrick Enright by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 16 issuers this person is listed on — nothing matched.
Websites and social links of the issuers Patrick Enright is listed on: none on file. No website or social profile named in BioAge Labs, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #106,092 of 374,652 in line (1,245 issuers searched so far). One-tap searches: Look further ↓
One-tap searches on sites we do not index ourselves, with the name pre-filled (Richmond, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.
No corrections have been requested for this page.
Free. Logged with status: received → under review → fixed / confirmed with source.
If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.
Members get an email when Patrick Enright appears on a new Form D, or when a court case or SEC action is matched to them. See plans →